Patients with rare, von Hippel Lindau (VHL) disease battle a series of malignant and benign tumours and cysts their whole lives. Patients and their carers are now hoping that NICE will recommend the use of a new drug, belzutifan (Welireg), the first ever non-surgical treatment to successfully target VHL tumours, via…
21st February, 2024